Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. - Wikidata - wikimedia - TriplyDB

Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.

Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.

http://www.wikidata.org/entity/Q27824801

about

EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma The natural history of EGFR and EGFRvIII in glioblastoma patients Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment Biomarkers for glioma immunotherapy: the next generation Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets Challenges to targeting epidermal growth factor receptor in glioblastoma: escape mechanisms and combinatorial treatment strategies Modern brain tumor imaging Case comparison and literature review of glioblastoma: A tale of two tumors Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma CIViC database A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.Afatinib, an irreversible ErbB family blocker, with protracted temozolomide in recurrent glioblastoma: a case report.Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma Mechanisms of action of therapeutic antibodies for cancer The future role of personalized medicine in the treatment of glioblastoma multiforme Epidemiologic and molecular prognostic review of glioblastoma EGFR Activation Leads to Cell Death Independent of PI3K/AKT/mTOR in an AD293 Cell Line Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter.ADAM-10-mediated N-cadherin cleavage is protein kinase C-alpha dependent and promotes glioblastoma cell migration.An extensive invasive intracranial human glioblastoma xenograft model: role of high level matrix metalloproteinase 9.Interactions between PTEN and receptor tyrosine kinase pathways and their implications for glioma therapy EGFR-targeted therapy in malignant glioma: novel aspects and mechanisms of drug resistance.Epidermal growth factor-induced enhancement of glioblastoma cell migration in 3D arises from an intrinsic increase in speed but an extrinsic matrix- and proteolysis-dependent increase in persistence.Use of (64)Cu-labeled fibronectin domain with EGFR-overexpressing tumor xenograft: molecular imaging.Benefits of dynamic susceptibility-weighted contrast-enhanced perfusion MRI for glioma diagnosis and therapy.Incorporating molecular tools into early-stage clinical trials iTRAQ-based proteomics profiling reveals increased metabolic activity and cellular cross-talk in angiogenic compared with invasive glioblastoma phenotype.RNA interference and nonviral targeted gene therapy of experimental brain cancer Clinical significance of EGFR amplification and the aberrant EGFRvIII transcript in conventionally treated astrocytic gliomas.RHBDD1 upregulates EGFR via the AP-1 pathway in colorectal cancer.Mutant EGFR is required for maintenance of glioma growth in vivo, and its ablation leads to escape from receptor dependence.Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors A novel 3D human glioblastoma cell culture system for modeling drug and radiation responses.Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas.Mig-6 controls EGFR trafficking and suppresses gliomagenesis ZD6474, a multitargeted inhibitor for receptor tyrosine kinases, suppresses growth of gliomas expressing an epidermal growth factor receptor mutant, EGFRvIII, in the brain

P2860

ba27c8e2173bd0ad8c5c46ee13a37e06e4e9bfc0

P248

Q24338526-80675501-AE4F-4663-A5FF-5AAEABA416E6 Q24548280-F69E9DA9-258D-42F6-A638-6DF772B68EBC Q24615166-754055DB-070E-4695-B95E-6171985ED078 Q24814477-E6357DD9-495C-4100-9755-D810ECCC175B Q26751473-2C70EB80-5403-40BE-AA9C-B57D9C611533 Q26785952-25759542-BC84-4874-9D8B-F3D766E01CD2 Q26825496-721AD52C-7171-4918-9556-C661A4309D60 Q26829873-14EFAF93-0D86-448B-9E89-4716F2FE73E3 Q26852366-A6A379B6-9133-495A-994E-8DC61A4D09AA Q27002344-B0134F07-41AC-43E5-82F7-0468C32B64E8 Q27014996-05F771A0-4F32-4F91-AE39-89A5F73FB4D0 Q27022941-2C84A05D-369F-4D78-988D-C78D6E4CC24A Q27612411-03072F6C-924A-401B-9A1E-59FD79494211 Q27853118-BF6AEE34-4CFA-4F87-9FF7-196F00797251 Q27853219-221F2FB4-7A36-476E-92E1-BD162C857582 Q28087306-1F967F06-5FAB-44FB-A2FC-8FE1DD369CBB Q28385366-E17F9C33-B633-4BA2-A664-64461C68598B Q28391635-7F781AA0-D8B6-4DFE-ABE8-F60E76167458 Q28395302-E99C1102-14C2-4401-B563-07F3273BF58A Q28551853-1F328B21-1304-45A0-A884-7A417D6B25CA Q30405446-CC9F589A-395B-4C91-8BFB-7E79A0FEDD23 Q30416775-25F74B45-C564-4EB9-BB23-028AF058DB0A Q30431424-3113F3CC-5001-4FB3-8340-4A25A4D8D312 Q30432036-7C92DF5F-FF87-41DB-B038-C590C7724006 Q30437740-6030EB2F-DFF1-42A8-9D72-51CE6F401D6F Q30456087-0A77E16C-648E-49E5-BFBA-97A8237391C1 Q30483791-D8F5D290-71B5-4FCF-BEA7-381D51FAF743 Q30511916-36397E6F-2F4E-4C47-B658-C0F43CAED61A Q30872679-FF4407A1-DE69-4043-9CF0-3BA1EAAE72BB Q33316159-89464E10-B96F-4382-BB0B-BF5D353139A7 Q33493026-03C6891F-953E-48F0-A0AB-2D46A33F4174 Q33569727-230AA081-AA2C-4545-9AB4-2DE935771601 Q33628302-1906A821-741A-420D-8E2D-DA23AC387E86 Q33648830-F1EDD438-7BDE-4617-B6D8-8DF89CA22D5D Q33664297-13EA10BD-663F-4F58-920C-525B3823248E Q33753135-6445F6E1-378F-415C-B92C-50CE313573DD Q33777423-6CCA515D-4A6C-4236-8510-7EB190EAF078 Q33809397-6B20FEEE-6B79-4FFC-ACBF-5CD22E745883 Q33859568-276055F9-A162-4EAE-9070-65D3A2E01471 Q33870872-71B89D7E-A7AB-49E6-BDB4-F83B0DACDC49

P2860

Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.

http://www.wikidata.org/entity/Q27824801

description

2003 nî lūn-bûn

@nan

2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Prognostic value of epidermal ...... with glioblastoma multiforme.

@ast

Prognostic value of epidermal ...... with glioblastoma multiforme.

@en

Prognostic value of epidermal ...... with glioblastoma multiforme.

@nl

type

label

Prognostic value of epidermal ...... with glioblastoma multiforme.

@ast

Prognostic value of epidermal ...... with glioblastoma multiforme.

@en

Prognostic value of epidermal ...... with glioblastoma multiforme.

@nl

prefLabel

Prognostic value of epidermal ...... with glioblastoma multiforme.

@ast

Prognostic value of epidermal ...... with glioblastoma multiforme.

@en

Prognostic value of epidermal ...... with glioblastoma multiforme.

@nl

P1433

Q27824801-4013AA51-D8CE-4479-9370-120D1D54FE57

P1476

Q27824801-E0DB9CE3-1C13-44DE-BDCD-D02F3726D4A6

P2093

Q27824801-0101C43C-12FC-4B32-B9AF-A8795CBE5207

Q27824801-0BFC9D7E-7DB8-4488-A8C4-F4162D0A8103

Q27824801-31A7BA8D-BAAD-41A7-90D9-FF44D678691C

Q27824801-31E14492-7064-4B90-9D6F-25556FC62BBF

Q27824801-5A43B3F5-4626-4AA3-A6E6-75886AC8734E

Q27824801-5D50C9D6-9A79-4A05-80AC-3B1E4E05E54D

Q27824801-99723EF2-55A0-4EF5-9D97-36037FB68C1A

Q27824801-A77EE18A-912E-45F3-95C2-1EDF1562DD6F

Q27824801-D815BB8A-B392-4919-9212-879D0AE9D004

Q27824801-DDC03512-BEBC-45C3-9E57-2F79DC2825B7

P304

Q27824801-3C265199-2BAD-4F15-83C1-CE1B04F20F8B

P31

Q27824801-C29BB8FE-F1B2-4EB4-8049-1AADF20C53F1

P3181

Q27824801-C6BB4E37-F202-4D25-B3FC-2E0238BD35F9

P407

Q27824801-FD6905CD-4BDF-427C-B853-3F2B31108F4C

P433

Q27824801-432E4B36-9A62-4AE4-A7C8-5F458AA762FF

P478

Q27824801-AB666FE5-B69A-4480-A3BB-DA27799BA4DB

P577

Q27824801-F48E7269-6D54-40DA-94BC-8C9B406CE047

P698

Q27824801-B69C041D-0044-4340-95EC-4D05A119A025

P3181

P1433

Cancer Research

P1476

Prognostic value of epidermal ...... s with glioblastoma multiforme

@en

P2093

Hideo Nakamura

http://www.w3.org/2001/XMLSchema#string

Hideyuki Saya

http://www.w3.org/2001/XMLSchema#string

Hirofumi Hirano

http://www.w3.org/2001/XMLSchema#string

Jun-Ichi Kuratsu

http://www.w3.org/2001/XMLSchema#string

Keishi Makino

http://www.w3.org/2001/XMLSchema#string

Kenji Tada

http://www.w3.org/2001/XMLSchema#string

Koji Oka

http://www.w3.org/2001/XMLSchema#string

Masato Kochi

http://www.w3.org/2001/XMLSchema#string

Naoki Shinojima

http://www.w3.org/2001/XMLSchema#string

Shoji Shiraishi

http://www.w3.org/2001/XMLSchema#string

P304

6962-6970

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

155468

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14583498

http://www.w3.org/2001/XMLSchema#string